Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.

Tcheng, J E

Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment. [electronic resource] - American heart journal Feb 2000 - S38-45 p. digital

Publication Type: Journal Article; Review

0002-8703

10.1067/mhj.2000.103742 doi


Eptifibatide
Hemorrhage--chemically induced
Humans
Myocardial Ischemia--blood
Peptides--adverse effects
Platelet Aggregation Inhibitors--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Recurrence
Risk Factors
Survival Rate
Thrombocytopenia--chemically induced
Tirofiban
Tyrosine--adverse effects